Clinical Trial Update: Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients [Phase 1]

View source ↗

Summary

Phase 1 trial comparing an HBV-MPL adjuvanted hepatitis B vaccine to Engerix-B in haemodialysis patients assessed immunogenicity, reactogenicity, and safety; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• HBV-MPL vaccine (HBV-MPL vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED